CASTLE ROCK, CO--(Marketwire - April 23, 2008) - AspenBio Pharma, Inc. (NASDAQ: APPY) an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for animals and humans, reported continued progress in its pre-clinical patient trials for the AppyScore™ human appendicitis blood-based diagnostic test, the first test of its kind in the world.
